Source link : https://www.breast-cancers.com/2020/02/14/cytodyn-reports-continued-positive-clinical-data-on-its-phase-1b-2-mtnbc-and-expanded-access-studies-for-mbc-ahead-of-breakthrough-therapy-designation-decision-from-the-fda-yahoo-finance/

CytoDyn Reports Continued Positive Clinical Data on its Phase 1b/2 mTNBC and Expanded Access Studies for MBC Ahead of Breakthrough Therapy Designation Decision From the FDA Yahoo Finance

Source link : https://finance.yahoo.com/news/cytodyn-reports-continued-positive-clinical-110010190.html

Author :

Publish date : 2020-02-14 11:00:00

Copyright for syndicated content belongs to the linked Source.

Author : breastcancers

Publish date : 2020-02-14 13:20:12

Copyright for syndicated content belongs to the linked Source.